BBLG

Bone Biologics Corporation BBLG

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BBLG HSCS VERO NAOV DHAI MOVE NDRA GCTK VTAK INM
6M -64.86 % -31.07 % -19.09 % -66.24 % -99.98 % 9.48 % 47.40 % -27.54 % -61.65 % -67.44 %
YTD -66.89 % -29.41 % -58.89 % -95.41 % -100.00 % -84.47 % -20.81 % -98.82 % -78.78 % -73.75 %
1Y -63.89 % -28.46 % -55.05 % -94.69 % -100.00 % -85.51 % -4.85 % -98.55 % -74.79 % -72.96 %
3Y -98.62 % -96.96 % -96.21 % -99.47 % -100.00 % -96.20 % -99.94 % -99.95 % -99.76 % -95.33 %
5Y -99.94 % -98.45 % -99.41 % -99.83 % -100.00 % -99.17 % -99.98 % -99.98 % -100.00 % -99.92 %
10Y -99.94 % -98.45 % -99.99 % -99.97 % -100.00 % -99.17 % -100.00 % -100.00 % -100.00 % -99.93 %
From the beginning -99.94 % -98.45 % -99.99 % -99.96 % -100.00 % -99.17 % -100.00 % -100.00 % -100.00 % -99.97 %

Dividend